nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adjuvant Sunitinib for Renal Cell Carcinoma: Still at the Beginning of the Road
|
Carretero-González, Alberto |
|
2018 |
2 |
1 |
p. 1-3 |
artikel |
2 |
Clinical Trials Corner
|
Powles, Thomas |
|
2018 |
2 |
1 |
p. 69-71 |
artikel |
3 |
Fourth-Line Therapy in Metastatic Renal Cell Carcinoma (mRCC): Results from the International mRCC Database Consortium (IMDC)
|
Stukalin, Igor |
|
2018 |
2 |
1 |
p. 31-36 |
artikel |
4 |
Impact of Aspirin and Non-Aspirin Nonsteroidal Anti-Inflammatory Drugs on Outcomes in Patients with Metastatic Renal Cell Carcinoma
|
Hamieh, Lana |
|
2018 |
2 |
1 |
p. 37-46 |
artikel |
5 |
Landmark Trials in Renal Cancer
|
Vaishampayan, Ulka |
|
2018 |
2 |
1 |
p. 11-21 |
artikel |
6 |
Non-Surgical Ablative Treatment of Distant Extracranial Metastases for Renal Cell Carcinoma: A Systematic Review
|
Verbiest, Annelies |
|
2018 |
2 |
1 |
p. 57-67 |
artikel |
7 |
Perioperative Statin Use and Acute Kidney Injury in Patients Undergoing Partial Nephrectomy
|
Joshi, Shreyas S. |
|
2018 |
2 |
1 |
p. 47-55 |
artikel |
8 |
Radical Nephrectomy is the Treatment of Choice for Complex, Localized Renal Tumors
|
Meissner, Matthew A. |
|
2018 |
2 |
1 |
p. 5-9 |
artikel |
9 |
Systematic Review: ClearCode 34 – A Validated Prognostic Signature in Clear Cell Renal Cell Carcinoma (ccRCC)
|
Ghatalia, Pooja |
|
2018 |
2 |
1 |
p. 23-29 |
artikel |